5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation
Open Access
- 21 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 11 (1), 1-13
- https://doi.org/10.1038/s41467-020-19173-2
Abstract
5-Fluorouracil (5-FU) remains the first-line treatment for colorectal cancer (CRC). Although 5-FU initially de-bulks the tumor mass, recurrence after chemotherapy is the barrier to effective clinical outcomes for CRC patients. Here, we demonstrate that p53 promotes WNT3 transcription, leading to activation of the WNT/beta -catenin pathway in Apc(Min/+)/Lgr5(EGFP) mice, CRC patient-derived tumor organoids (PDTOs) and patient-derived tumor cells (PDCs). Through this regulation, 5-FU induces activation and enrichment of cancer stem cells (CSCs) in the residual tumors, contributing to recurrence after treatment. Combinatorial treatment of a WNT inhibitor and 5-FU effectively suppresses the CSCs and reduces tumor regrowth after discontinuation of treatment. These findings indicate p53 as a critical mediator of 5-FU-induced CSC activation via the WNT/beta -catenin signaling pathway and highlight the significance of combinatorial treatment of WNT inhibitor and 5-FU as a compelling therapeutic strategy to improve the poor outcomes of current 5-FU-based therapies for CRC patients. The relative enrichment of cancer stem cells after treatment results in tumour recurrence. Here, the authors show a mechanism where p53 induces WNT3, which increases the number of colorectal cancer stem cells following treatment of 5-fluorouracil.Funding Information
- National Research Foundation of Korea (2018R1D1A1B07050189, 2019R1A2C3002751)
This publication has 44 references indexed in Scilit:
- A colorectal cancer classification system that associates cellular phenotype and responses to therapyNature Medicine, 2013
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patientsAnnals of Oncology, 2012
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant TherapyJNCI Journal of the National Cancer Institute, 2011
- Paneth cells constitute the niche for Lgr5 stem cells in intestinal cryptsNature, 2010
- A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerClinical Cancer Research, 2009
- Wnt/β-Catenin Is Essential for Intestinal Homeostasis and Maintenance of Intestinal Stem CellsMolecular and Cellular Biology, 2007
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005